SPATA31D1
gene geneOn this page
Also known as FLJ46321
Summary
SPATA31D1 (SPATA31 subfamily D member 1, HGNC:37283) is a protein-coding gene on chromosome 9q21.32, encoding Spermatogenesis-associated protein 31D1 (Q6ZQQ2). May play a role in spermatogenesis.
Predicted to be involved in cell differentiation and spermatogenesis. Predicted to be located in membrane.
Source: NCBI Gene 389763 — RefSeq curated summary.
At a glance
- GWAS associations: 7
- Clinical variants (ClinVar): 403 total
- MANE Select transcript:
NM_001001670
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:37283 |
| Approved symbol | SPATA31D1 |
| Name | SPATA31 subfamily D member 1 |
| Location | 9q21.32 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ46321 |
| Ensembl gene | ENSG00000214929 |
| Ensembl biotype | protein_coding |
| Entrez | 389763 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 1 protein_coding, 1 retained_intron
ENST00000344803, ENST00000603921
RefSeq mRNA: 1 — MANE Select: NM_001001670
NM_001001670
CCDS: CCDS47986
Canonical transcript exons
ENST00000344803 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001366546 | 81988772 | 81989004 |
| ENSE00001371473 | 81990417 | 81990486 |
| ENSE00001385751 | 81990773 | 81995253 |
| ENSE00001777782 | 81989778 | 81989823 |
Expression profiles
Bgee: expression breadth broad, 17 present calls, max score 92.47.
Top tissues by expression
231 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sperm | CL:0000019 | 92.47 | gold quality |
| upper arm skin | UBERON:0004263 | 89.06 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 87.72 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 86.04 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 84.94 | gold quality |
| cardia of stomach | UBERON:0001162 | 84.85 | gold quality |
| kidney epithelium | UBERON:0004819 | 83.75 | gold quality |
| vena cava | UBERON:0004087 | 82.07 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 81.00 | gold quality |
| superficial temporal artery | UBERON:0001614 | 80.84 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 80.82 | gold quality |
| vastus lateralis | UBERON:0001379 | 80.61 | gold quality |
| ventral tegmental area | UBERON:0002691 | 80.42 | gold quality |
| myocardium | UBERON:0002349 | 80.28 | gold quality |
| subthalamic nucleus | UBERON:0001906 | 80.16 | gold quality |
| right testis | UBERON:0004534 | 80.11 | gold quality |
| dorsal plus ventral thalamus | UBERON:0001897 | 79.83 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 79.43 | gold quality |
| left testis | UBERON:0004533 | 79.21 | gold quality |
| body of tongue | UBERON:0011876 | 79.19 | gold quality |
| quadriceps femoris | UBERON:0001377 | 79.18 | gold quality |
| tongue | UBERON:0001723 | 79.15 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 79.11 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 78.99 | gold quality |
| superior surface of tongue | UBERON:0007371 | 78.93 | gold quality |
| inferior vagus X ganglion | UBERON:0005363 | 77.90 | gold quality |
| pharyngeal mucosa | UBERON:0000355 | 77.89 | gold quality |
| superior vestibular nucleus | UBERON:0007227 | 77.86 | gold quality |
| pons | UBERON:0000988 | 77.77 | gold quality |
| lateral globus pallidus | UBERON:0002476 | 77.68 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 2.94 |
Regulation
Is transcription factor: no
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Spata31f3 | ENSMUSG00000050141 |
| rattus_norvegicus | ENSRNOG00000089661 |
Paralogs (13): SPATA31C2 (ENSG00000177910), SPATA31E1 (ENSG00000177992), SPATA31A6 (ENSG00000185775), SPATA31D3 (ENSG00000186788), SPATA31F3 (ENSG00000187791), SPATA31D4 (ENSG00000189357), SPATA31A1 (ENSG00000204849), SPATA31F1 (ENSG00000205108), SPATA31C1 (ENSG00000230246), (ENSG00000251545), SPATA31A3 (ENSG00000275969), SPATA31A7 (ENSG00000276040), SPATA31A5 (ENSG00000276581)
Protein
Protein identifiers
Spermatogenesis-associated protein 31D1 — Q6ZQQ2 (reviewed: Q6ZQQ2)
Alternative names: Protein FAM75D1
All UniProt accessions (1): Q6ZQQ2
UniProt curated annotations — full annotation on UniProt →
Function. May play a role in spermatogenesis.
Subcellular location. Membrane.
Similarity. Belongs to the SPATA31 family.
RefSeq proteins (1): NP_001001670* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR027970 | SPATA31-like | Domain |
| IPR039509 | SPATA31 | Domain |
Pfam: PF14650, PF15371
UniProt features (11 total): region of interest 5, compositionally biased region 4, chain 1, transmembrane region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6ZQQ2-F1 | 40.19 | 0.02 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 12 (showing top):
GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8_TCELL_IFNAR_KO_DN, DARWICHE_SKIN_TUMOR_PROMOTER_DN, DARWICHE_PAPILLOMA_RISK_LOW_DN, DARWICHE_PAPILLOMA_RISK_HIGH_DN, DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN, GOBP_MALE_GAMETE_GENERATION, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, chr9q21, GOBP_SEXUAL_REPRODUCTION, GOBP_REPRODUCTIVE_PROCESS, GOBP_MULTICELLULAR_ORGANISMAL_REPRODUCTIVE_PROCESS, GSE37605_C57BL6_VS_NOD_FOXP3_FUSION_GFP_TREG_UP
GO Biological Process (2): spermatogenesis (GO:0007283), cell differentiation (GO:0030154)
GO Molecular Function (0):
GO Cellular Component (1): membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| developmental process involved in reproduction | 1 |
| male gamete generation | 1 |
| cellular developmental process | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
448 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SPATA31D1 | TMEM202 | A6NGA9 | 580 |
| SPATA31D1 | SCP2D1 | Q9UJQ7 | 482 |
| SPATA31D1 | DDX10 | Q13206 | 476 |
| SPATA31D1 | DCAF8L2 | P0C7V8 | 434 |
| SPATA31D1 | ZNF738 | Q8NE65 | 419 |
| SPATA31D1 | RASEF | Q8IZ41 | 400 |
| SPATA31D1 | NKAIN3 | Q8N8D7 | 395 |
| SPATA31D1 | MTNAP1 | Q9BSJ5 | 390 |
| SPATA31D1 | GRID1 | Q9ULK0 | 379 |
| SPATA31D1 | GRIK3 | Q13003 | 372 |
| SPATA31D1 | GRID2 | O43424 | 369 |
| SPATA31D1 | ZC2HC1A | Q96GY0 | 368 |
| SPATA31D1 | SPNS3 | Q6ZMD2 | 366 |
| SPATA31D1 | GRM7 | Q14831 | 362 |
| SPATA31D1 | GRIK1 | P39086 | 360 |
IntAct
0 interactions, top by confidence:
BioGRID (2): SPATA31D1 (Cross-Linking-MS (XL-MS)), LDHA (Cross-Linking-MS (XL-MS))
ESM2 similar proteins: A0A096LP49, A6NGG8, A6NNH2, B1ASB6, B4DYI2, B6VQA5, C0HKD1, C0HKD2, C0HKD3, D2J0Y4, D6RGX4, E9QAF0, P0C874, P0DKV0, Q149B8, Q3KR64, Q4R736, Q4V8B5, Q5TZJ5, Q5VU36, Q5VVP1, Q5VWK0, Q5VYM1, Q5VYP0, Q63HN1, Q658T7, Q68A65, Q6NS69, Q6NXZ1, Q6PAC4, Q6ZQQ2, Q6ZU69, Q6ZUB0, Q6ZUB1, Q7TSA6, Q80X53, Q86Y26, Q8BHP2, Q8BHW6, Q8C0D9
Diamond homologs: B4DYI2, B6VQA5, E9QAF0, P0C874, P0DKV0, Q5TZJ5, Q5VU36, Q5VVP1, Q5VYP0, Q6ZQQ2, Q6ZUB0, Q6ZUB1, Q8IWB4, A6NFA0, C0HKD1, C0HKD2, C0HKD3, Q32LN6, Q63HN1, Q642A3, Q6ZU69, Q80YD3
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
403 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 368 |
| Likely benign | 31 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
636 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 9:81990758:T:A | acceptor_gain | 1.0000 |
| 9:81990758:T:TA | acceptor_gain | 1.0000 |
| 9:81989001:AAAGG:A | donor_loss | 0.9900 |
| 9:81989002:AAGGT:A | donor_loss | 0.9900 |
| 9:81989003:AGGTA:A | donor_loss | 0.9900 |
| 9:81989005:G:C | donor_loss | 0.9900 |
| 9:81989006:T:A | donor_loss | 0.9900 |
| 9:81990759:G:A | acceptor_gain | 0.9900 |
| 9:81990400:T:G | acceptor_gain | 0.9800 |
| 9:81990764:T:TA | acceptor_gain | 0.9800 |
| 9:81990908:G:GT | donor_gain | 0.9700 |
| 9:81988862:GGC:G | donor_gain | 0.9600 |
| 9:81990771:A:AG | acceptor_gain | 0.9600 |
| 9:81990772:G:GG | acceptor_gain | 0.9600 |
| 9:81989776:AGCAT:A | acceptor_gain | 0.9500 |
| 9:81990312:T:A | acceptor_gain | 0.9500 |
| 9:81990768:T:A | acceptor_gain | 0.9500 |
| 9:81990413:TCA:T | acceptor_loss | 0.9400 |
| 9:81990415:A:AC | acceptor_loss | 0.9400 |
| 9:81990482:AAAAG:A | donor_loss | 0.9400 |
| 9:81990483:AAAG:A | donor_loss | 0.9400 |
| 9:81990484:AAGGT:A | donor_loss | 0.9400 |
| 9:81990485:AGGTG:A | donor_loss | 0.9400 |
| 9:81990486:GGTGA:G | donor_loss | 0.9400 |
| 9:81990487:GTG:G | donor_loss | 0.9400 |
| 9:81990488:T:A | donor_loss | 0.9400 |
| 9:81990768:TGCA:T | acceptor_loss | 0.9400 |
| 9:81990769:GCA:G | acceptor_loss | 0.9400 |
| 9:81990771:AGCTT:A | acceptor_loss | 0.9400 |
| 9:81990772:G:A | acceptor_loss | 0.9400 |
AlphaMissense
10332 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 9:81991980:T:C | F504L | 0.972 |
| 9:81991982:C:A | F504L | 0.972 |
| 9:81991982:C:G | F504L | 0.972 |
| 9:81993198:T:C | F910L | 0.937 |
| 9:81993200:C:A | F910L | 0.937 |
| 9:81993200:C:G | F910L | 0.937 |
| 9:81992499:T:C | F677L | 0.928 |
| 9:81992501:T:A | F677L | 0.928 |
| 9:81992501:T:G | F677L | 0.928 |
| 9:81988915:A:C | S33R | 0.904 |
| 9:81988917:T:A | S33R | 0.904 |
| 9:81988917:T:G | S33R | 0.904 |
| 9:81992004:A:C | S512R | 0.903 |
| 9:81992006:C:A | S512R | 0.903 |
| 9:81992006:C:G | S512R | 0.903 |
| 9:81990843:T:C | C125R | 0.901 |
| 9:81990858:T:C | C130R | 0.892 |
| 9:81991986:G:C | G506R | 0.891 |
| 9:81988924:G:A | G36R | 0.887 |
| 9:81988924:G:C | G36R | 0.887 |
| 9:81993150:T:C | F894L | 0.877 |
| 9:81993152:C:A | F894L | 0.877 |
| 9:81993152:C:G | F894L | 0.877 |
| 9:81988837:T:C | F7L | 0.876 |
| 9:81988839:T:A | F7L | 0.876 |
| 9:81988839:T:G | F7L | 0.876 |
| 9:81992064:T:C | F532L | 0.870 |
| 9:81992066:C:A | F532L | 0.870 |
| 9:81992066:C:G | F532L | 0.870 |
| 9:81992568:T:A | W700R | 0.868 |
dbSNP variants (sampled 300 via entrez): RS1000657091 (9:81987927 A>T), RS1000675618 (9:81987549 T>G), RS1000735265 (9:81992608 T>C), RS1003520806 (9:81986193 G>A), RS1003658107 (9:81985825 A>G), RS1003734372 (9:81995631 T>A), RS1004081601 (9:81991256 T>C,G), RS1004320959 (9:81988316 C>G,T), RS1004480271 (9:81992863 G>A,C), RS1004529913 (9:81987248 C>T), RS1004664026 (9:81987056 A>C), RS1005193943 (9:81989873 C>A,G,T), RS1005220728 (9:81991991 C>G,T), RS1005329640 (9:81989533 A>G), RS1005901026 (9:81993754 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
7 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002941_11 | Airway imaging phenotypes | 7.000000e-07 |
| GCST004521_104 | Autism spectrum disorder or schizophrenia | 2.000000e-08 |
| GCST004946_105 | Schizophrenia | 2.000000e-08 |
| GCST006803_104 | Schizophrenia | 8.000000e-11 |
| GCST007257_11 | Broad depression or schizophrenia | 2.000000e-09 |
| GCST007576_102 | Chronotype | 3.000000e-10 |
| GCST009391_2094 | Metabolite levels | 6.000000e-06 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007627 | airway imaging measurement |
| EFO:0008328 | chronotype measurement |
| EFO:0010373 | phosphatidylcholine 32:1 measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
3 total (human), top 3 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.